Seminar Nasional Kefarmasian 2016

Penguatan Rantai Pasok Nasional di Era MEA

Bandung, 14 Mei 2016

KOLABORASI RANTAI
PASOK DI INDUSTRI
FARMASI INDONESIA

Dr. Erlinda Yunus

Outline
Collaboration in supply chain

Collaboration benefits

Research findings
 Heroes may win battles
but it is capable supply chains that
win wars (against disease)

Privett & Gonsalvez (2014)

 Top 10 global health pharmaceutical supply chain issues

Privett & Gonsalvez (2014)

 Coordination Cooperation Collaboration
1

3
Lets achieve common Lets improve Lets create something
activity something new

Level of Purpose or Goal >>>

Alone we can do so little; together we can do so much

Helen Keller
Collaboration
A tailored business relationship based on
mutual trust, openness, shared risk and shared
rewards that yields a competitive advantage,
resulting in business performance greater that
would be achieved by the firms individually
(Lambert et al., 1996: p. 2)
 Information IT Capability &
Sharing Integration
Supply Chain
Collaboration
Communication Logistics
& Coordination Synchronization
BENEFITS OF COLLABORATION

Time-Cost Improved Improved

Savings Quality Competitiveness

Improved
Lead time
customer
reduction Improved material
satisfaction
choices

Improved schedule
Better service level
attainment

Better handling
Increased forecast and delivery Better, faster
accuracy innovations
Collaboration between the parties involved in the
healthcare provision will contribute to make the
industry more efficient.

The supply chains for designing, manufacturing

and distributing pharmaceuticals and medical
devices plus those providing healthcare services
will integrate so that all partners can see the full
picture and help them plan ahead more
accurately and cost-effective.

PwC Report: Pharma 2020: Supplying the Future

 Forward Collaboration

Backward
Collaboration
Knowledge-
Intensive
Coopetition Collaboration
Research findings
Collaboration among Pharmaceutical Companies in Indonesia
 Fill Rate
25

Number of
companies
14
10

< 50% 75 - <85% 85 - <95% 95% or more

25 Inventory Turnover
20 22

15
Number of
companies 12
10
9
5 6
3
0
3x - <6x 6x - <9x 9x - <12x 12x - <15x 15x or more
CIC-PPM Research 2015-2016
 Revenue Growth in the Last Three Years
20
Number of
companies
18

16

14

12

10

>50% >40-50% >30-40% >20-30% >15-20% >10-15% >5-10% 0-2%

CIC-PPM Research 2015-2016

 Profit Growth in the Last Three Years
Number of 18
companies
16

14

12

10

0
>50% >40-50% >30-40% >20-30% >15-20% >10-15% >5-10% >2-5% 0-2% Negative

CIC-PPM Research 2015-2016

PwC Report: Pharma 2020: Supplying the Future
PwC Report: Pharma 2020: Supplying the Future
 KOLABORASI PERUSAHAAN FARMASI
INDONESIA
Interdependence
5.00

Performance 4.00 Trust

3.00

2.00

1.00
Long-term
Collaboration BUMN-A
Orientation
- Private-B
Swasta-A

Coordination Information
Structure Sharing

IT Capability Inventory System

 The Framework

t = 6,17** t = 6,24**
Supply Chain Supplier-Retailer Supplier-Retailer
Architecture Collaboration Performance

Sample size: 52 pharmaceutical companies

Legend: ** significant (p < 0.01)

CIC-PPM Research 2015-2016

 APOTEKER >> as a Manager
in the Pharmaceutical
Industry

Supply Chain Managers

plan, develop, optimize, orga
nize, direct, manage, evaluat
e, and are accountable
and/or responsible for some
or all of the supply chains
processes of organizations.

ROLE OF SUPPLY CHAIN MANAGER